Resveratrol nanosuspensions: Interaction of preservatives with nanocrystal production

Pharmazie

Volumn 66, Issue 12, 2011, Pages 942-947

  Kobierski, S ^a   Ofori Kwakye, K ^a,b   Muller R H ^a   Keck, Cornelia M ^c,d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPRYLYLGLYCOL; EUXYL PE 9010; HYDROLITE 5; MULTIEX NARCOTIC; NANOCRYSTAL; PHENONIP; PRESERVATIVE; RESVERATROL; ROKONSAL PB 5; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DISPERSION; DRUG STABILITY; LASER DIFFRACTION; MICROSCOPY; PHOTON CORRELATION SPECTROSCOPY; SUSPENSION; THERMODYNAMICS; ZETA POTENTIAL;

ANTIOXIDANTS; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; DRUG STORAGE; ELECTROCHEMISTRY; INDICATORS AND REAGENTS; NANOPARTICLES; PARTICLE SIZE; PRESERVATIVES, PHARMACEUTICAL; RUTIN; STILBENES; SUSPENSIONS; WATER;

EID: 84855703508     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.1038     Document Type: Article

References (19)

1. Afaq F, Adhami VM, Ahmad N (2003) Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol Appl Pharmacol 186: 28-37. (Pubitemid 36262946)
2. Bowers VD, Locker S, Ames S, Jennings W, Corry RJ (1991) The hemodynamic effects of Cremophor-EL. Transplantation 51: 847-850.
3. Chan MMY (2002) Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 63: 99-104.
4. Chen Y, Lu Y, Chen J, Lai J, Sun J, Hu F, Wu W (2009) Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 376: 153-160.
5. Diederichs J (1993) PhD - thesis, Freie Universität Berlin.
6. Ehlers S, Bucke W, Leitzke S, Fortmann L, Smith D, Hansch H, Hahn H, Bancroff G, Müller R (1996) Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings. Zentralbl Bakteriol 284: 218-231. (Pubitemid 26350355)
7. Gu X, Creasy L, Kester A, Zeece M (1999) Capillary electrophoretic determination of resveratrol in wines. J Agricult Food Chem 47: 3223-3227. (Pubitemid 29422018)
8. Keck CM (2006) PhD - thesis, Freie Universität Berlin.
9. Keck CM, Müller RH (2008) Smart Crystals® - Nanodiamanten zur Erhöhung der Bioaktivität. Labor&More 1: 64-65.
10. Kirby C, Clarke J, Gregoriadis G (1980) Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 186: 591-598.
11. Kobierski S, Ofori-Kwakye K, Müller RH, Keck CM (2009) Resveratrol nanosuspensions for dermal application-production, characterization, and physical stability. Pharmazie 64: 741-747.
12. Lucks JS, Müller BW, Müller RH (1990) Inorganic suspensions - interaction with salts and ionic surfactants. Int J Pharm 58: 229-235. (Pubitemid 20079738)
13. Müller RH (1996) Zetapotential und Partikelladung, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
14. Petersen RD (2008) PCT/EP2007/009943.
15. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526.
16. Renaud S, de Lorgeril M (1993) The French paradox: dietary factors and cigarette smoking-related health risks. Ann N Y Acad Sci 686: 299-309. (Pubitemid 23204435)
17. Sigma, Resveratrol product information.
18. Stewart JR, Artime MC, O'Brian CA (2003) Resveratrol: a candidate nutritional substance for prostate cancer prevention. J Nutr 133: 2440S-2443S. (Pubitemid 36828851)
19. Vemuri S, Rhodes CT (1995) Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helv 70: 95-111.